Sotera Health Announces Fourth-Quarter and Full-Year 2024 Earnings Release Date
Sotera Health Company (Nasdaq: SHC), a leading global provider of sterilization solutions and lab testing services for the healthcare industry, has scheduled its fourth-quarter and full-year 2024 financial results release for Thursday, February 27, 2025, before market opening.
The company will host a conference call at 9:00 a.m. Eastern Time to discuss operating highlights and financial results. Participants can join by dialing 1-844-481-2916 (US) or 1-412-317-0709 (international locations). A live webcast and accompanying materials will be accessible through the company's Investor Relations website, with a replay available later that day.
Sotera Health Company (Nasdaq: SHC), un fornitore globale leader di soluzioni di sterilizzazione e servizi di test di laboratorio per l'industria sanitaria, ha programmato la pubblicazione dei risultati finanziari del quarto trimestre e dell'anno intero 2024 per giovedì 27 febbraio 2025, prima dell'apertura del mercato.
L'azienda ospiterà una conferenza telefonica alle 9:00 a.m. Eastern Time per discutere i punti salienti operativi e i risultati finanziari. I partecipanti possono unirsi componendo il numero 1-844-481-2916 (USA) o 1-412-317-0709 (località internazionali). Sarà disponibile un webcast dal vivo e materiali correlati attraverso il sito web delle Relazioni con gli Investitori dell'azienda, con una registrazione disponibile più tardi durante la giornata.
Sotera Health Company (Nasdaq: SHC), un proveedor global líder de soluciones de esterilización y servicios de pruebas de laboratorio para la industria de la salud, ha programado la publicación de sus resultados financieros del cuarto trimestre y del año completo 2024 para el jueves 27 de febrero de 2025, antes de la apertura del mercado.
La compañía realizará una conferencia telefónica a las 9:00 a.m. Hora del Este para discutir los aspectos destacados operativos y los resultados financieros. Los participantes pueden unirse marcando el 1-844-481-2916 (EE. UU.) o el 1-412-317-0709 (localidades internacionales). Habrá una transmisión en vivo y materiales complementarios accesibles a través del sitio web de Relaciones con Inversores de la compañía, con una repetición disponible más tarde ese mismo día.
소테라 헬스 컴퍼니 (Nasdaq: SHC), 의료 산업을 위한 멸균 솔루션 및 실험실 테스트 서비스의 글로벌 선두 제공업체,는 2024년 4분기 및 연간 재무 결과 발표를 2025년 2월 27일 목요일 시장 개장 전에 예정했습니다.
회사는 운영 하이라이트 및 재무 결과를 논의하기 위해 동부 표준시 기준 오전 9시에 컨퍼런스 콜을 개최합니다. 참가자는 1-844-481-2916 (미국) 또는 1-412-317-0709 (국제 전화)로 전화하여 참여할 수 있습니다. 회사의 투자자 관계 웹사이트를 통해 실시간 웹캐스트와 관련 자료에 접근할 수 있으며, 그날 나중에 재생이 가능합니다.
Sotera Health Company (Nasdaq: SHC), un fournisseur mondial de premier plan de solutions de stérilisation et de services de tests de laboratoire pour l'industrie de la santé, a prévu la publication de ses résultats financiers du quatrième trimestre et de l'année 2024 pour jeudi 27 février 2025, avant l'ouverture du marché.
La société animera une conférence téléphonique à 9h00, heure de l'Est, pour discuter des faits saillants opérationnels et des résultats financiers. Les participants peuvent se joindre en composant le 1-844-481-2916 (États-Unis) ou le 1-412-317-0709 (localités internationales). Un webinaire en direct et des documents d'accompagnement seront accessibles via le site Internet des relations avec les investisseurs de la société, avec un enregistrement disponible plus tard dans la journée.
Sotera Health Company (Nasdaq: SHC), ein führender globaler Anbieter von Sterilisationslösungen und Labortestdiensten für die Gesundheitsbranche, hat die Veröffentlichung seiner finanziellen Ergebnisse für das 4. Quartal und das Gesamtjahr 2024 für Donnerstag, den 27. Februar 2025, vor Markteröffnung angesetzt.
Das Unternehmen wird um 9:00 Uhr Eastern Time eine Telefonkonferenz abhalten, um betriebliche Höhepunkte und finanzielle Ergebnisse zu besprechen. Teilnehmer können sich unter 1-844-481-2916 (USA) oder 1-412-317-0709 (internationale Standorte) einwählen. Eine Live-Webcast und begleitende Materialien werden über die Investor-Relations-Website des Unternehmens zugänglich sein, mit einer Wiederholung, die später am Tag verfügbar ist.
- None.
- None.
CLEVELAND, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results for the fourth-quarter and full-year ended December 31, 2024 before the market opens on Thursday, February 27, 2025. Following the release, management will hold a conference call at 9:00 a.m. Eastern Time to discuss the Company’s operating highlights and financial results.
To participate in the live call, please dial 1-844-481-2916 if dialing-in from the United States, or 1-412-317-0709 if dialing-in from other locations. A live webcast of the conference call can be accessed at this link or via the Investor Relations section of the Company’s website at Presentation & Events | Sotera Health, along with the accompanying materials. A replay of the webcast will be available later in the day on February 27th.
Updates can be found from time to time on recent developments in matters relevant to investors on the Investor Relations section of the Company’s website at Investor Relations | Sotera Health. For developments related to Ethylene Oxide, updates can be found at Ethylene Oxide | Sotera Health.
About Sotera Health
Sotera Health Company is a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. Sotera Health goes to market through three businesses – Sterigenics®, Nordion® and Nelson Labs®. Sotera Health is committed to its mission, Safeguarding Global Health®.
INVESTOR RELATIONS CONTACTS:
Jason Peterson
Vice President, Investor Relations & Treasurer
IR@soterahealth.com
MEDIA CONTACT:
Kristin Gibbs
Chief Marketing Officer
kgibbs@soterahealth.com
Source: Sotera Health Company
FAQ
When will Sotera Health (SHC) release Q4 and full-year 2024 earnings?
How can investors join Sotera Health's Q4 2024 earnings call?
Will there be a replay available for SHC's Q4 2024 earnings call?
Where can investors find updates on Sotera Health's (SHC) Ethylene Oxide developments?
